Hailshadow/iStock via Getty Images Entrada Therapeutics ( TRDA ) sold off on Thursday as investors reacted to initial data from an early-stage trial for ENTR-601-44, its experimental therapy targeting the rare genetic muscular disorder known as Duchenne muscular dystrophy. Citing data from its Phase 1/2 ELEVATE-44-201 trial, the Massachusetts-based biotech said that compared to placebo, ENTR-601-4...
Hailshadow/iStock via Getty Images Entrada Therapeutics ( TRDA ) sold off on Thursday as investors reacted to initial data from an early-stage trial for ENTR-601-44, its experimental therapy targeting the rare genetic muscular disorder known as Duchenne muscular dystrophy. Citing data from its Phase 1/2 ELEVATE-44-201 trial, the Massachusetts-based biotech said that compared to placebo, ENTR-601-44 led to a statistically significant 0.115 mean change in Time to Rise velocity, an established endpoint in Phase 3 trials for Duchenne. However, the results didn’t impress Wall Street, with Entrada ( TRDA ) shares crashing ~55% to a five-month low on a day the company reported its Q1 2026 results with ELEVATE-44-201 data. The readout represented eight patients aged 6 - 17 with Duchenne who enrolled in Cohort 1 of the multiple ascending dose portion of the global trial, which targeted Duchenne patients aged 4 - 20 whose DMD gene is amenable to a treatment mechanism called "exon 44 skipping." Regarding safety, Entrada ( TRDA ) indicated a favorable tolerability profile for the intravenous therapy, noting that there were no serious adverse events or adverse events that led to trial discontinuations. All eight trial subjects have progressed to the open-label portion of the study. The company expects to report the open-label portion of ELEVATE-44-201 and the Cohort 2 MAD portion of the trial by the end of this year. More on Entrada Therapeutics Seeking Alpha’s Quant Rating on Entrada Therapeutics Historical earnings data for Entrada Therapeutics Financial information for Entrada Therapeutics
Investors Title press release ( ITIC ): Q1 GAAP EPS of $3.20. Revenues increased 13.2% to $64.0 million. More on Investors Title Investors Title: Still A Hold, Waiting For A Dip Investors Title Company: Strong Fundamentals, Litigation Overhangs, Hold For Now (Rating Downgrade) Historical earnings data for Investors Title Dividend scorecard for Investors Title Financial information for Investors Ti...
Investors Title press release ( ITIC ): Q1 GAAP EPS of $3.20. Revenues increased 13.2% to $64.0 million. More on Investors Title Investors Title: Still A Hold, Waiting For A Dip Investors Title Company: Strong Fundamentals, Litigation Overhangs, Hold For Now (Rating Downgrade) Historical earnings data for Investors Title Dividend scorecard for Investors Title Financial information for Investors Title
Luis Alvarez Activist investor TOMS Capital Investment Management repeated a call for Voya Financial ( VOYA ) to start a strategic review after reporting its Q1 results. “As we recently expressed, Voya is one of the most compelling and undervalued franchises in financial services," TOMS Capital said in a statement on Thursday. "Voya has outperformed peers in delivering consistent net inflows, rece...
Luis Alvarez Activist investor TOMS Capital Investment Management repeated a call for Voya Financial ( VOYA ) to start a strategic review after reporting its Q1 results. “As we recently expressed, Voya is one of the most compelling and undervalued franchises in financial services," TOMS Capital said in a statement on Thursday. "Voya has outperformed peers in delivering consistent net inflows, recently surpassing $1 trillion in assets while prudently avoiding aggressive private credit risk. Our issue is not with Voya’s franchise quality; we are investors because of it. Rather, our issue is with current management’s lack of urgency, as its stubbornness to change course has jarringly de-rated the multiple." The latest call from TOMS comes after the Financial Times reported last month that the activist investor had built a stake in Voya ( VOYA ) and was pushing for the company to put itself up for sale or offload its underperforming health insurer arm. "Hope is not a strategy," TOMS added in the statement. "Voya’s leaders must exercise their fiduciary duties and initiate a formal review of all strategic alternatives.” More on Voya Financial Voya Financial, Inc. 2026 Q1 - Results - Earnings Call Presentation Voya Financial, Inc. (VOYA) Q1 2026 Earnings Call Transcript Voya Financial: Right On Fundamentals, But The Re-Rating Is Delayed (Rating Downgrade) Voya outlines $150M Q2 buybacks while targeting 2-plus % organic growth Voya Financial Q1 2026 Earnings Preview
Wall Street delivered a split verdict on Uber Technologies (NYSE:UBER) following the company’s Q1 2026 earnings report on May 6. Goldman Sachs (NYSE:GS) lowered its price target to $115 from $125 while maintaining a Buy rating, and Piper Sandler (NYSE:PIPR) analyst Thomas Champion raised his target to $105 from $100 while keeping an Overweight rating. ... Wall Street Splits on Uber: Goldman Sachs ...
Wall Street delivered a split verdict on Uber Technologies (NYSE:UBER) following the company’s Q1 2026 earnings report on May 6. Goldman Sachs (NYSE:GS) lowered its price target to $115 from $125 while maintaining a Buy rating, and Piper Sandler (NYSE:PIPR) analyst Thomas Champion raised his target to $105 from $100 while keeping an Overweight rating. ... Wall Street Splits on Uber: Goldman Sachs Cuts Price Target While Piper Sandler Hikes
Exzeo Group, Inc. press release ( XZO ): Q1 GAAP EPS of $0.22 beats by $0.01 . Revenue of $55.5M (+5.9% Y/Y) misses by $2.56M . Net income of $20.4M. More on Exzeo Group, Inc. Exzeo Group, Inc. (XZO) Q1 2026 Earnings Call Transcript Exzeo: Under The Radar And Gleaming Exzeo Group, Inc. (XZO) Q4 2025 Earnings Call Transcript Exzeo outlines $115M-$125M 2026 pretax income outlook while targeting $1.5...
Exzeo Group, Inc. press release ( XZO ): Q1 GAAP EPS of $0.22 beats by $0.01 . Revenue of $55.5M (+5.9% Y/Y) misses by $2.56M . Net income of $20.4M. More on Exzeo Group, Inc. Exzeo Group, Inc. (XZO) Q1 2026 Earnings Call Transcript Exzeo: Under The Radar And Gleaming Exzeo Group, Inc. (XZO) Q4 2025 Earnings Call Transcript Exzeo outlines $115M-$125M 2026 pretax income outlook while targeting $1.55B managed premium Exzeo Group raises 2026 managed premium outlook to $1.55B as AI adoption accelerates platform growth
OceanaGold Corporation press release ( OGC:CA ): Q1 GAAP EPS of $1.01. Revenue of $714.5M (+98.5% Y/Y). Declared dividend of $0.09 per share, payable June 19, 2026, to shareholders of record May 20, 2026. More on OceanaGold Corporation OceanaGold Corporation (OGC:CA) Presents at PDAC Conference 2026 - Slideshow OceanaGold Corporation 2025 Q4 - Results - Earnings Call Presentation OceanaGold Corpor...
OceanaGold Corporation press release ( OGC:CA ): Q1 GAAP EPS of $1.01. Revenue of $714.5M (+98.5% Y/Y). Declared dividend of $0.09 per share, payable June 19, 2026, to shareholders of record May 20, 2026. More on OceanaGold Corporation OceanaGold Corporation (OGC:CA) Presents at PDAC Conference 2026 - Slideshow OceanaGold Corporation 2025 Q4 - Results - Earnings Call Presentation OceanaGold Corporation (OGC:CA) Q4 2025 Earnings Call Transcript Historical earnings data for OceanaGold Corporation Dividend scorecard for OceanaGold Corporation
Citigroup issued new guidance showing it would take the lender more time to catch up to Wall Street peers than some investors hoped for. Sridhar Natarajan reports on Bloomberg Television. (Source: Bloomberg)
Citigroup issued new guidance showing it would take the lender more time to catch up to Wall Street peers than some investors hoped for. Sridhar Natarajan reports on Bloomberg Television. (Source: Bloomberg)
At least 29 passengers of 12 nationalities left the MV Hondius on 24 April after the first fatality Where did the cruise ship hantavirus come from and what happens next? Europe live – latest updates Authorities around the world are racing to trace dozens of passengers who disembarked from the cruise ship at the centre of a deadly hantavirus outbreak before isolation measures were implemented. It e...
At least 29 passengers of 12 nationalities left the MV Hondius on 24 April after the first fatality Where did the cruise ship hantavirus come from and what happens next? Europe live – latest updates Authorities around the world are racing to trace dozens of passengers who disembarked from the cruise ship at the centre of a deadly hantavirus outbreak before isolation measures were implemented. It emerged for the first time on Thursday that at least 29 passengers of 12 nationalities left the MV Hondius on 24 April after the first fatality, prompting a scramble to identify and track their movements since then. Continue reading...